0G8X.LImmunovia AB

Acerca de

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

www.immunovia.com

Estadísticas clave

Cap. de mercado

66.38M

BPA

-0.42

Rend. dividendo

0.00%

Beta

2.68

P/VC

1.21

ROE

-225.4%

Sector

Healthcare

Industria

Medical - Pharmaceuticals

CEO

Jeff Borcherding

Empleados

13

Fecha IPO

2018-01-26

País

SE